Notable Stocks: Vermillion, Imprimis Pharmaceuticals Inc, MELA Sciences Inc, Spectrum Pharmaceuticals

Lakeway, TX -- (SBWIRE) -- 03/14/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Vermillion, Inc.(NASDAQ:VRML) lost 7.25% and closed at $1.28. Vermillion, Inc. is engaged in the discovery, development and commercialization of diagnostic tests that helps physicians diagnose, treat and improve outcomes for patients.

How Should Investors Trade VRML After The Recent Movement? Find Out Here

Imprimis Pharmaceuticals Inc(NASDAQ:IMMY) decreased 8.17% and closed at $5.51. Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products.

Is IMMY Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

MELA Sciences Inc(NASDAQ:MELA) lost 5.88% and closed at $1.12. MELA Sciences, Inc. is a medical device company focused on the commercialization of its product, MelaFind, and the further design and development of MelaFind and its technology.

Is MELA a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) moved down 37.33% and closed at $7.79. Spectrum Pharmaceuticals, Inc. (Spectrum) is a biotechnology company with integrated commercial and drug development operations with a focus in hematology and oncology. In the United States, it markets two oncology drugs, ZEVALIN and FUSILEV and have two drugs, apaziquone and belinostat, in late stage development along with a pipeline of drug candidates.

How Should Investors Trade SPPI After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.